lopinavir has been researched along with Bile Duct Obstruction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Igari, H; Ishii, I; Nakada, TA; Sayama, M; Suzuki, T; Yamazaki, S | 1 |
| Carini, E; Castagna, A; Danise, A; Dorigatti, F; Galli, L; Gentilini, G; Hasson, H; Lazzarin, A; Seminari, E; Soldarini, A | 1 |
2 other study(ies) available for lopinavir and Bile Duct Obstruction
| Article | Year |
|---|---|
Suspected cholestatic liver injury induced by favipiravir in a patient with COVID-19.
Topics: Aged; Amides; Antiviral Agents; Chemical and Drug Induced Liver Injury; Cholestasis; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Extracorporeal Membrane Oxygenation; Humans; Lopinavir; Male; Pyrazines; Ritonavir; SARS-CoV-2 | 2021 |
Higher plasma lopinavir concentrations are associated with a moderate rise in cholestasis markers in HIV-infected patients.
Topics: Adult; Alanine Transaminase; Alkaline Phosphatase; Anti-HIV Agents; Bilirubin; Biomarkers; Cholestasis; Female; gamma-Glutamyltransferase; HIV Infections; Humans; Lopinavir; Male; Pyrimidinones; Retrospective Studies | 2005 |